These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33452801)

  • 21. Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents.
    Castiglione F; Mainenti P; Testa A; Imperatore N; De Palma GD; Maurea S; Rea M; Nardone OM; Sanges M; Caporaso N; Rispo A
    Dig Liver Dis; 2017 May; 49(5):484-489. PubMed ID: 28292640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmural healing evaluated by bowel sonography in patients with Crohn's disease on maintenance treatment with biologics.
    Castiglione F; Testa A; Rea M; De Palma GD; Diaferia M; Musto D; Sasso F; Caporaso N; Rispo A
    Inflamm Bowel Dis; 2013 Aug; 19(9):1928-34. PubMed ID: 23835441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease.
    Dassopoulos T; Frangakis C; Cruz-Correa M; Talor MV; Burek CL; Datta L; Nouvet F; Bayless TM; Brant SR
    Inflamm Bowel Dis; 2007 Feb; 13(2):143-51. PubMed ID: 17206688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
    Forbes JD; Chen CY; Knox NC; Marrie RA; El-Gabalawy H; de Kievit T; Alfa M; Bernstein CN; Van Domselaar G
    Microbiome; 2018 Dec; 6(1):221. PubMed ID: 30545401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmural Healing Is Associated with Improved Long-term Outcomes of Patients with Crohn's Disease.
    Fernandes SR; Rodrigues RV; Bernardo S; Cortez-Pinto J; Rosa I; da Silva JP; Gonçalves AR; Valente A; Baldaia C; Santos PM; Correia L; Venâncio J; Campos P; Pereira AD; Velosa J
    Inflamm Bowel Dis; 2017 Aug; 23(8):1403-1409. PubMed ID: 28498158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.
    Kugathasan S; Denson LA; Walters TD; Kim MO; Marigorta UM; Schirmer M; Mondal K; Liu C; Griffiths A; Noe JD; Crandall WV; Snapper S; Rabizadeh S; Rosh JR; Shapiro JM; Guthery S; Mack DR; Kellermayer R; Kappelman MD; Steiner S; Moulton DE; Keljo D; Cohen S; Oliva-Hemker M; Heyman MB; Otley AR; Baker SS; Evans JS; Kirschner BS; Patel AS; Ziring D; Trapnell BC; Sylvester FA; Stephens MC; Baldassano RN; Markowitz JF; Cho J; Xavier RJ; Huttenhower C; Aronow BJ; Gibson G; Hyams JS; Dubinsky MC
    Lancet; 2017 Apr; 389(10080):1710-1718. PubMed ID: 28259484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn's Disease.
    Weinstein-Nakar I; Focht G; Church P; Walters TD; Abitbol G; Anupindi S; Berteloot L; Hulst JM; Ruemmele F; Lemberg DA; Leach ST; Cytter R; Greer ML; Griffiths AM; Turner D;
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1089-1097.e4. PubMed ID: 29501599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmural Response and Transmural Healing Defined by Intestinal Ultrasound: New Potential Therapeutic Targets?
    Helwig U; Fischer I; Hammer L; Kolterer S; Rath S; Maaser C; Kucharzik T
    J Crohns Colitis; 2022 Jan; 16(1):57-67. PubMed ID: 34185843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.
    Doherty MK; Ding T; Koumpouras C; Telesco SE; Monast C; Das A; Brodmerkel C; Schloss PD
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn's Disease Strictures Ex Vivo.
    Truffi M; Sorrentino L; Monieri M; Fociani P; Mazzucchelli S; Bonzini M; Zerbi P; Sampietro GM; Di Sabatino A; Corsi F
    Inflamm Bowel Dis; 2018 Jan; 24(2):332-345. PubMed ID: 29361086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inter-radiologist agreement using Society of Abdominal Radiology-American Gastroenterological Association (SAR-AGA) consensus nomenclature for reporting CT and MR enterography in children and young adults with small bowel Crohn disease.
    Rees MA; Dillman JR; Anton CG; Rattan MS; Smith EA; Towbin AJ; Zhang B; Trout AT
    Abdom Radiol (NY); 2019 Feb; 44(2):391-397. PubMed ID: 30120514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Bowel Inflammation and Strictures by Magnetic Resonance Enterography in Long-term Crohn's Disease.
    Lunder AK; Bakstad LT; Jahnsen J; Borthne A; Hov JR; Vatn M; Negård A
    J Crohns Colitis; 2019 Apr; 13(5):607-614. PubMed ID: 30541145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
    Gathungu G; Kim MO; Ferguson JP; Sharma Y; Zhang W; Ng SM; Bonkowski E; Ning K; Simms LA; Croft AR; Stempak JM; Walker N; Huang N; Xiao Y; Silverberg MS; Trapnell B; Cho JH; Radford-Smith GL; Denson LA
    Inflamm Bowel Dis; 2013 Jul; 19(8):1671-80. PubMed ID: 23749272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can Conventional and Diffusion-Weighted MR Enterography Biomarkers Differentiate Inflammatory from Fibrotic Strictures in Crohn's Disease?
    Foti PV; Travali M; Farina R; Palmucci S; Coronella M; Spatola C; Puzzo L; Garro R; Inserra G; Riguccio G; Zanoli L; Basile A
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33803953
    [No Abstract]   [Full Text] [Related]  

  • 37. Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.
    Haberman Y; BenShoshan M; Di Segni A; Dexheimer PJ; Braun T; Weiss B; Walters TD; Baldassano RN; Noe JD; Markowitz J; Rosh J; Heyman MB; Griffiths AM; Crandall WV; Mack DR; Baker SS; Kellermayer R; Patel A; Otley A; Steiner SJ; Gulati AS; Guthery SL; LeLeiko N; Moulton D; Kirschner BS; Snapper S; Avivi C; Barshack I; Oliva-Hemker M; Cohen SA; Keljo DJ; Ziring D; Anikster Y; Aronow B; Hyams JS; Kugathasan S; Denson LA
    Inflamm Bowel Dis; 2018 Jan; 24(2):346-360. PubMed ID: 29361088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Fecal Calprotectin a Useful Marker for Small Bowel Crohn Disease?
    D'Arcangelo G; Imondi C; Terrin G; Catassi G; Aloi M
    J Pediatr Gastroenterol Nutr; 2021 Aug; 73(2):242-246. PubMed ID: 33872293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luminal Narrowing Alone Allows an Accurate Diagnosis of Crohn's Disease Small Bowel Strictures at Cross-Sectional Imaging.
    Stocker D; King MJ; El Homsi M; Carbonell G; Bane O; Cuevas J; Liu Q; Cho J; Doucette JT; Greenstein AJ; Colombel JF; Harpaz N; Taouli B
    J Crohns Colitis; 2021 Jun; 15(6):1009-1018. PubMed ID: 33319236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Danese S; Sandborn WJ; Colombel JF; Vermeire S; Glover SC; Rimola J; Siegelman J; Jones S; Bornstein JD; Feagan BG
    Gastroenterology; 2019 Oct; 157(4):1007-1018.e7. PubMed ID: 31279871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.